The Beginnings Semaglutide was initially developed as a medication to help people with type 2 diabetes manage their condition
This marks the second round of enforcement action since the agency's September crackdown on misleading pharmaceutical ads
Wegovy was approved in 2021 for chronic weight management in adults who are obese or overweight and have at least one weight-related condition
Eur J Neurosci 17(4):813821 Gate D, Saligrama N, Leventhal O, Yang AC, Unger MS, Middeldorp J, Chen K, Lehallier B, Channappa D, De Los Santos MB, McBride A, Pluvinage J, Elahi F, Tam GK, Kim Y, Greicius M, Wagner AD, Aigner L, Galasko DR, Davis MM, Wyss-Coray T (2020) Clonally expanded CD8 T cells patrol the cerebrospinal fluid in Alzheimers disease